基本信息
浏览量:390
职业迁徙
个人简介
Dr. Stupp has been the lead investigator for numerous clinical trials from first-in-human phase 1 to pivotal phase 3 registration studies. In the brain tumor field, he is best known for his contributions of temozolomide (Temodar®) and radiation in the first line treatment of brain tumors (the “stupp protocol”), and establishing MGMT as a predictive marker for benefit from alkylating agent chemotherapy. He was also the lead investigator establishing Tumor Treating Fields (Optune®) as an innovative treatment modality. Two novel treatments that based on his research received FDA approval and are today standard of care for patients suffering from glioblastoma.
研究兴趣
论文共 476 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Nature Communicationsno. 1 (2024): 1-12
Priya Kumthekar,Madison Lyleroehr, Leilani Lacson,Rimas V. Lukas, Karan Dixit,Roger Stupp, Timothy Kruser, Jeff Raizer, Alexander Hou, Sean Sachdev, Margaret Schwartz, Jessica Bajas PA,
BMC Cancerno. 1 (2024): 1-11
Neuro-oncology advancesno. Supplement_3 (2023): iii37-iii38
Julien Laurent, Eveline Faes-van't Hull,Cedric Touvrey,François Kuonen,Qiang Lan,Girieca Lorusso, Marie-Agnès Doucey,Laura Ciarloni,Natsuko Imaizumi,Gian Carlo Alghisi,Ernesta Fagiani, Khalil Zaman,
crossref(2023)
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn